The infectivity of sarcoid clinical material and its bacterial content inoculated in CBA mice

In Vivo

Volumn 20, Issue 6 B, 2006, Pages 807-814

  Ikonomopoulos, John ^a   Gazouli, Maria ^a,b   Dontas, Ismini ^b   Sechi, Leonardo ^c   Lukas, John C ^d   Balaskas, Christos ^a   Gorgoulis, Vassilis ^b   Kittas, Christos ^b  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Mycobacteria; Propionibacteria; Sarcoidosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCLAVE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FOOT PAD; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INOCULATION; LUNG LAVAGE; LUNG SARCOIDOSIS; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROPIONIBACTERIUM ACNES; PROPIONIBACTERIUM GRANULOSUM; SPUTUM;

EID: 33846071674     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Siltzbach LE, James DG, Neville E, Turiaf J, Battesi JP, Sharma OP, Hosoda Y, Mikami R and Odaka M: Course of prognosis of sarcoidosis around the world. Am J Med 57: 847-852, 1974.
2. Neville E, Walker AN and James DG: Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52: 525-533, 1983.
3. Baughman RP, Lower EE and du Bois RM: Sarcoidosis. Lancet 361: 1111-1118, 2003.
4. Nunes H, Soler P and Valeyre D: Pulmonary sarcoidosis. Allergy 60: 565-582, 2005.
5. McGrath DS, Goh N, Foley PJ and du Bois RM: Sarcoidosis genes and microbes: soil or seed. Sarcoidosis Vasc Diffuse Lung Dis 18: 149-164, 2001.
6. Popper HH, Klemen H, Hoefler G and Winter E: Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 28: 796-800, 1997.
7. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C and Gorgoulis V: Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 40: 3060-3063, 2002.
8. Ishige I, Usui Y, Takemura T and Eishi Y: Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354: 120-123, 1999.
9. Alberti LD, Piatelli A, Artese L, Favia G, Patel S and Saunders N: Human herpesvirus 8 variants in sarcoid tissues. Lancet 350: 1655-1661, 1997.
10. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V and Barreton G: Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 22: 66-74, 2005.
11. Mitchel IC and Turk JL: Observations on the Kveim reaction using an animal model of granulomatous bowel disease. Gut 32: 159-162, 1991.
12. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ and Moller DR: Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201: 755-767, 2005.
13. Minami J, Eishi Y, Ishige Y, Kobayashi I, Ishige I, Kobayashi D, Ando N, Uchida K, Ikeda S, Sorimachi N, Karasuyama H, Takemura T, Takizawa T and Kolke M: Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. J Med Dent Sci 50: 265-274, 2003.
14. Gupta UD and Katoch VW: Animal models of tuberculosis. Tuberculosis 85: 277-293, 2005.
15. Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H, Kuriyama T and Matsushlma K: Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 165: 631-639, 2004.
16. Hettinga DH, Vedamuthu ER and Reinbold GW: Pouch method for isolating and numerating propionibacteria. J Dairy Sci 51: 1707-1709, 1968.
17. Mitchell DN and Rees RWJ: A transmissible agent from sarcoid tissue. Lancet 2: 81-84, 1969.
18. Grizzanti NJ and Rosenstreich LD: Effect of inoculation of sarcoid tissue into athymic (nude) mice. Sarcoidosis 5: 136-141, 1998.
19. Richard W, Belcher MD, John D and Reid MD: Sarcoid granulomas in CBA/J mice. Arch Pathol 99: 283-285, 1975.
20. Iwai K and Takahashi S: Transmissibility of sarcoid-specific granulomas in the footpads of mice. Ann NY Acad Sci 278: 249-259, 1976.
21. Mitchell DN, Rees RJ and Goswami KK: Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 2: 761-765, 1976.
22. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G and Sharma OP: ATS/ERS/WASOG statement on sarcoidodis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatons Disorders. Sarcoidosis Vase Diffuse Lung Dis 16: 149-173, 1999.
23. Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Galanos AA, Karameris A and Kittas C: Experimental inoculation of laboratory animals with samples collected from sarcoidal patients and molecular diagnostic evaluation of the results. In Vivo 14: 761-765, 2000.
24. Yi ES, Lee H, Suh YK, Tang W, Qi M, Yin S, Remick DG and Ulich TR: Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am J Pathol 149: 1303-1312, 1996.
25. Medina E, Rogerson BJ and North RJ: The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 88: 479-481, 1996.
26. Chackerian A, Alt J, Perera V and Behar SM: Activation of NKT cells protects mice from tuberculosis. Infect Immun 70: 6302-6309, 2002.
27. Gazouli M, Ikonomopoulos J, Koundourakis A, Bartos M, Pavlik I, Overduin P, Kremer K, Gorgoulis V and Kittas C: Characterization of Mycobacterium tuberculosis complex isolates from Greek patients with sarcoidosis, by spoligotyping. J Clin Microbiol 43: 4858-4861, 2005.
28. Newman LS, Rose CS and Maier LA: Sarcoidosis. N Engl J Med 336: 1224-1234, 1997.
29. Rook GA, Adams V, Hunt J, Palmer R, Martinelli R and Brunet LR: Mycobacteria and other environmental organisms as immunomodulators for immunoregnlatory disorders. Springer Semin Immunopathol 25: 237-255, 2004.